Home Biosimilar Antibodies TGF-beta/Smad TGF-beta/Smad antibody Fresolimumab (Anti-TGFb1) For research use only.
Not for use in humans.

Fresolimumab (Anti-TGFb1)

Synonyms: GC1008

Fresolimumab (Anti-TGFb1) is a pan-specific, recombinant, fully human monoclonal antibody directed against human transforming growth factor (TGF) beta 1, 2, and 3 with potential antineoplastic activity. MW : 145.5 KD.

Fresolimumab (Anti-TGFb1)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 3.85mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective TGF-beta/Smad Inhibitors

Biological Activity

Description Fresolimumab (Anti-TGFb1) is a pan-specific, recombinant, fully human monoclonal antibody directed against human transforming growth factor (TGF) beta 1, 2, and 3 with potential antineoplastic activity. MW : 145.5 KD.

Product Details

CAS No. 948564-73-6
Molecular Weight 145.5 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Fresolimumab (Anti-TGFb1) | Fresolimumab (Anti-TGFb1) supplier | purchase Fresolimumab (Anti-TGFb1) | Fresolimumab (Anti-TGFb1) cost | Fresolimumab (Anti-TGFb1) manufacturer | order Fresolimumab (Anti-TGFb1) | Fresolimumab (Anti-TGFb1) distributor